• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through early October 2024

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through early October 2024

by Truveta staff | Oct 28, 2024 | Research

Overall, the rate of hospitalizations associated with respiratory viruses decreased throughout September 2024 and into the first week of October. For infants and children aged 0-4 years old, respiratory virus-associated hospitalizations increased slightly by 2.9%...
Hurricane Helene: Impact of IV fluid shortage on patients

Hurricane Helene: Impact of IV fluid shortage on patients

by Truveta Research | Oct 25, 2024 | Research, Research Insights

For patients coming into the emergency department (ED) with nausea/vomiting or dehydration, patients are half as likely to receive IV fluids starting 10 days after the hurricane compared to prior to Hurricane Helene. We expect these numbers to continue to decrease. ...
GLP-1 RA prescription trends: January 2018 – September 2024

GLP-1 RA prescription trends: January 2018 – September 2024

by Truveta staff | Oct 14, 2024 | Research

Overall prescribing rates for GLP-1 medications increased in September 2024 relative to June 2024 (+11.9%). While the rate of GLP-1 prescriptions labeled for type 2 diabetes were about the same as June 2024 (+4.0%), the rate of prescriptions for GLP-1 medications...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through August 2024

Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through August 2024

by Truveta staff | Sep 19, 2024 | Research

Overall, the rate of hospitalizations associated with respiratory viruses remained stable throughout August 2024, with no change compared to July 2024. For infants and children aged 0-4 years old, respiratory virus-associated hospitalizations increased significantly...
Real-time monitoring of viral gastroenteritis: August 2024

Real-time monitoring of viral gastroenteritis: August 2024

by Truveta staff | Sep 11, 2024 | Research

The overall trends of hospitalizations associated with viral gastroenteritis – norovirus and rotavirus – show a steady decrease over the last few months, leading to a rate of 0.04% in August 2024 in the overall population. However, we see first indicators that the...
ISPE 2024: Exploring the impact of removing race as a diagnostic factor for chronic kidney disease: Time to potassium-lowering drugs

ISPE 2024: Exploring the impact of removing race as a diagnostic factor for chronic kidney disease: Time to potassium-lowering drugs

by Truveta Research | Aug 23, 2024 | Research, Research Insights

Authors: Charlotte Baker DrPH MPH CPH ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin Cartwright ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc, Bellevue, WA, Samuel Gratzl PhD ⊕Truveta, Inc, Bellevue, WA, Nicholas Stucky, MD PhD ⊕Truveta,...
« Older Entries
Next Entries »

Share this


Recent posts

  • Real-world survival outcomes for CRT and CCM therapies align with landmark trials
  • Understanding the potential impact of the upcoming ACIP vote on thimerosal-containing influenza vaccines
  • Biosimilar use is on the rise – but 1 in 8 patients return to Humira

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice